| |
|
|
Recommendations - Anthrax |
|
|
|
Use of Anthrax Vaccine in
the United States: Recommendations of the Advisory Committee on
Immunization Practices (ACIP), 2009
Source: MMWR, July 23, 2010;
59(rr06):1-36 |
|
| HTML | PDF |
| |
Use of Anthrax Vaccine in Response
to Terrorism
Source: MMWR, November 15, 2002, Vol. 51(45):1024-1026 |
|
| HTML | PDF |
| |
Use of Anthrax
Vaccine in the United States
Source: MMWR December 15, 2000 / Vol. 49 / No. RR-15 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Chickenpox (varicella) |
|
|
|
Prevention of Varicella
Source: MMWR, June 22, 2007; 56(RR-4):1-40 |
|
| HTML | PDF |
| |
Investigational Product
(VariZIG™) for Postexposure Prophylaxis of Varicella
Source: MMWR, February 24, 2006, Vol. 55:1-2 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Diphtheria |
|
|
|
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee
on Immunization Practices (ACIP)
Source: MMWR, February 22, 2013;62(07):131-5 |
|
|
HTML | PDF |
|
|
| |
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine
in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
Source: MMWR, June 29, 2012; 61(25):468-70 |
|
|
HTML | PDF |
|
| |
Updated Recommendations for Use of
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis
Vaccine (Tdap) in Pregnant Women and Persons Who Have or
Anticipate Having Close Contact with an Infant Aged <12 Months --
Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426 |
|
|
HTML | PDF |
| |
Updated Recommendations for Use of
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis
(Tdap) Vaccine from the Advisory Committee on Immunization
Practices, 2010
Source:: MMWR, January 14,
2011; 60(01):13-15 |
|
|
HTML | PDF |
| |
Prevention of Pertussis, Tetanus, and
Diphtheria Among Pregnant and Postpartum Women and Their Infants:
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 30, 2008; 57
(04):1-47,51 |
|
|
HTML pt 1 |
HTML pt 2 |
HTML pt 3 |
PDF |
| |
Preventing Tetanus,
Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced
Diphtheria Toxoid and Acellular Pertussis Vaccine
Please
note: If you are using the HTML version of this document, be sure to access
all four HTML links to get the complete content of the document,
which includes 3 important appendices.
Source: MMWR, December 15, 2006;55(RR-17):1-33 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | PDF
(entire issue) |
| |
Use of Tetanus Toxoid,
Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among
Adolescents
Please
note: If you are using the HTML version of this document, be sure to access
all the HTML links to get the complete content of the document,
which includes important appendices.
Source: MMWR, March
24, 2006, Vol. 55(RR03):1-49 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | HTML
pt.5 | HTML
pt.6 | HTML
pt.7 | PDF
(entire issue) |
| |
Use of Diphtheria
Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose
Series
Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13 |
|
| HTML | PDF |
| |
Diphtheria,
Tetanus, and Pertussis, Recommendations for Vaccine Use and Other
Preventive Measures
Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Haemophilus influenzae type b (Hib) |
Back to top |
|
|
|
Licensure of a Haemophilus
influenzae Type b (Hib) Vaccine (Hiberix) and Updated Recommendations
for Use of Hib Vaccine
Source: MMWR September 18, 2009;
58(36):1008-1009 |
|
| HTML | PDF |
| |
Updated Recommendations for Use of
Haemophilus influenzae Type b (Hib) Vaccine: Reinstatement of the Booster
Dose at Ages 12 -15 Months
Source: MMWR, June 26, 2009; 58(24):673-4 |
|
| HTML | PDF |
| |
Use of Haemophilus
b Conjugate Vaccines and a Combined DTP and Hib Vaccine
Source: MMWR September 17, 1993 / Vol. 42 / No. RR-13 |
|
| HTML | PDF |
| |
Haemophilus
b Conjugate Vaccines for Prevention of Hib Disease
Source: MMWR January 11, 1991 / Vol. 40 / No. RR-01 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Hepatitis A |
|
|
|
Sexually Transmitted Diseases
Treatment Guidelines, 2010
(Not an ACIP statement but an
important document. Includes information on hepatitis A, hepatitis
B, and human papillomavirus [HPV] vaccination.)
Source: MMWR, December 17, 2010; 59(RR12):1-110 |
|
|
HTML | PDF |
| |
Updated Recommendations from
the Advisory Committee on Immunization Practices (ACIP) for Use of
Hepatitis A Vaccine in Close Contacts of Newly Arriving International
Adoptees
Source: MMWR, September 18, 2009;
58(36):1006-1007 |
|
| HTML | PDF |
| |
Update: Prevention
of Hepatitis A after Exposure to Hepatitis A Virus and in
International Travelers
Source: MMWR, October 19, 2007; 56(41):1080-1084 |
|
| HTML | PDF |
| |
Prevention of Hepatitis
A Through Active or Passive Immunization
Source: MMWR, May 19, 2006, Vol. 55(RR07):1-23 |
|
| HTML | PDF |
| |
Correctional Settings: Prevention and
Control of Infections with Hepatitis Viruses in Correctional Settings
(not an ACIP statement but an important document)
Source: MMWR, January 24, 2003, Vol. 52(RR-1):1-44 |
|
| HTML | PDF |
| # |
|
|
|
|
Updated CDC Recommendations
for the Management of Hepatitis B Virus–Infected Health-Care
Providers and Students
(Not an ACIP statement
but an important document from CDC.)
Source: MMWR, July 6,
2012; 61(RR03):1-12 |
|
|
HTML | PDF |
| |
Use of Hepatitis B Vaccination for Adults with Diabetes Mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, December 23, 2011; 60(50):1709-11 |
|
| HTML | PDF |
| |
Sexually Transmitted Diseases
Treatment Guidelines, 2010
(Not an ACIP statement but an
important document. Includes information on hepatitis A, hepatitis
B, and human papillomavirus [HPV] vaccination.)
Source: MMWR, December 17, 2010; 59(RR12):1-110 |
|
|
HTML | PDF |
| |
Recommendations
for Identification and Public Health Management of Persons with Chronic
Hepatitis B Virus Infection
Source: MMWR, September 19, 2008; 57(RR--8):1-20
(Not an ACIP statement, but an important new recommendation from CDC) |
|
| HTML | PDF |
| |
A Comprehensive Immunization
Strategy to Eliminate Transmission of Hepatitis B Virus Infection
in the United States. Part II: Immunization of Adults
Please note: If you are using
the HTML version of this document, be sure to access all four
HTML links to get the complete content of the document, which
includes 3 important appendices.
Source: MMWR, December 8, 2006;55(RR-16):1-25R |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | PDF
(entire issue) |
| |
A Comprehensive Immunization
Strategy to Eliminate Transmission of Hepatitis B Virus Infection
in the United States. Part 1: Immunization of Infants, Children
and Adolescents.
Please note: If you are using the HTML version of this document, be sure
to access all four HTML links to get the complete content of the document,
which includes 3 important appendices.
Source: MMWR, December
23, 2005, Vol. 54(RR-16):1-39 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | PDF
(entire issue) |
| |
Correctional Settings: Prevention and
Control of Infections with Hepatitis Viruses in Correctional Settings
(not an ACIP statement but an important document)
Source: MMWR, January 24, 2003, Vol. 52(RR-1):1-44 |
|
| HTML | PDF |
| |
Management of
Occupational Exposures to HBV, HCV, and HIV and Recommendations
for Postexposure Prophylaxis
(not an ACIP statement but an important update document)
Source: MMWR June 29, 2001 / Vol. 50 / No. RR-11 |
|
| HTML | PDF |
| |
Recommendations
for Preventing Transmission of Human Immunodeficiency Virus and
Hepatitis B Virus to Patients During Exposure-Prone Invasive Procedures
(not an ACIP statement but an important document)
Source: MMWR, July 12, 1991 / Vol. 40 / No. RR08 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Human papillomavirus (HPV) |
Back to top |
|
|
|
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8 |
|
| HTML | PDF |
| |
Sexually Transmitted Diseases
Treatment Guidelines, 2010
(Not an ACIP statement but an
important document. Includes information on hepatitis A, hepatitis
B, and human papillomavirus [HPV] vaccination.)
Source: MMWR, December 17, 2010; 59(RR12):1-110 |
|
|
HTML | PDF |
| |
FDA Licensure of Bivalent
Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and
Updated HPV Vaccination Recommendations from the Advisory Committee on
Immunization Practices (ACIP)
Source: MMWR, May 28, 2010;
59(20):626-629 |
|
| HTML | PDF |
| |
FDA Licensure of
Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in
Males and Guidance from the Advisory Committee on Immunization
Practices (ACIP) Weekly
Source: MMWR, May 28, 2010;
59(20):630-632 |
|
| HTML | PDF |
| |
Quadrivalent
Human Papillomavirus Vaccine
Source: MMWR, March 23, 2007; 56(RR02):1-24 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Influenza |
|
|
|
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2012–13
Influenza Season
Source: MMWR, August 18, 2012;61(32);613-8 |
|
|
HTML | PDF |
| |
Antiviral Agents for the
Treatment and Chemoprophylaxis of Influenza
Source: MMWR, January 21, 2011; 60(RR01):1-24 |
|
|
HTML | PDF |
| |
Licensure of a High-Dose
Inactivated Influenza Vaccine for Persons Aged >=65 Years (Fluzone
High-Dose) and Guidance for Use--United States, 2010
Source: MMWR, April 30, 2010; 59(16):485-486 |
|
| HTML | PDF |
| |
Expansion of Use of Live Attenuated
Influenza Vaccine (FluMist) to Children Aged 2-4 Years and Other
FluMist Changes for the 2007--08 Influenza Season
Source: MMWR, November
23, 2007; 56(46):1217-1219 |
|
| HTML | PDF |
| |
Influenza Vaccination
of Health-Care Personnel
Source: MMWR, February 24, 2006, Vol. 55(RR02):1-16 |
|
| HTML | PDF |
| |
Using Live, Attenuated Influenza Vaccine
for Prevention and Control of Influenza
Source: MMWR, September 26, 2003, Vol. 52/No. RR-13 (file size 402 KB) |
|
| HTML | PDF |
| # |
|
|
Recommendations - Japanese Encephalitis |
|
|
|
Recommendations for Use of a
Booster Dose of Inactivated Vero Cell Culture-Derived Japanese
Encephalitis Vaccine -- Advisory Committee on Immunization
Practices, 2011
Source: MMWR, May 27, 2011;
60(20):661-3 |
|
|
HTML | PDF |
| |
Update on Japanese Encephalitis
Vaccine for Children
Source: MMWR, May 27, 2011; 60(20):664-5 |
|
HTML | PDF |
|
| |
Japanese Encephalitis Vaccines
Source: MMWR, March 12, 2010;
59(01):1-27 |
|
| HTML | PDF |
| |
|
|
|
|
ACIP Provisional Recommendations
Prevention of Measles, Rubella, Congenital Rubella Syndrome (CRS),
and Mumps
Source: Centers for Disease Control and Prevention, December 6,
2012 |
|
|
HTML | PDF |
| |
Use of Combination Measles,
Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory
Committee on Immunization Practices
Source: MMWR, May 7, 2010; 59(RR--3):1 - 16 |
|
| HTML | PDF |
| |
Measles, Mumps,
and Rubella--Vaccine Use and Strategies
Source: MMWR May 22, 1998 / Vol. 47 / No. RR-8 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Meningococcal |
|
|
|
Prevention and Control of
Meningococcal Disease: Recommendations of the Advisory Committee
on Immunization Practices (ACIP)
Source: MMWR, March 22,
2013; 62(RR02):1-22 |
|
|
HTML | PDF |
| |
Infant Meningococcal Vaccination:
Advisory Committee on Immunization Practices (ACIP)
Recommendations and Rationale
Source: MMWR, January 25,
2013; 62(3):52-4 |
|
|
HTML | PDF |
| |
Recommendation of the Advisory
Committee on Immunization Practices (ACIP) for Use of Quadrivalent
Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9
Through 23 Months at Increased Risk for Invasive Meningococcal
Disease
Source: MMWR, October 14, 2011; 60(40):1391-2 |
|
|
HTML | PDF |
| |
Licensure of a Meningococcal
Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated
Booster Dose Guidance for Adolescents and Other Persons at
Increased Risk for Meningococcal Disease — Advisory Committee on
Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011;
60(30):1018-1019 |
|
|
HTML | PDF |
| |
Updated Recommendations
for Use of Meningococcal Conjugate Vaccines--Advisory Committee on
Immunization Practices (ACIP), 2010
Source: MMWR, January 28, 2011; 60(03):72-76 |
|
|
HTML | PDF |
| |
Licensure of a Meningococcal
Conjugate Vaccine (Menveo) and Guidance for Use--Advisory Committee on
Immunization Practices (ACIP), 2010
Source: MMWR, March 12, 2010;
59(09):273 |
|
| HTML | PDF |
| |
Updated Recommendation from
the Advisory Committee on Immunization Practices (ACIP) for
Revaccination of Persons at Prolonged Increased Risk for Meningococcal
Disease
Source: MMWR, September 25, 2009; 58(37):1042-1043 |
|
| HTML | PDF |
| |
Recommendation
from the Advisory Committee on Immunization Practices (ACIP) for
Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children
Aged 2--10 Years at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, December 7, 2007; 56(48):1265-1266 |
|
| HTML | PDF |
| |
Revised Recommendations
of the ACIP to Vaccinate All Persons Aged 11--18 Years with Meningococcal
Conjugate Vaccine
Source: MMWR, August 10, 2007; 56(31):794-795 |
|
| HTML | PDF |
| |
Prevention and Control of Meningococcal
Disease
Source: MMWR, May 27, 2005, Vol. 54(RR07):1-21 |
|
| HTML | PDF |
| # |
|
|
|
|
ACIP Provisional Recommendations
Prevention of Measles, Rubella, Congenital Rubella Syndrome (CRS),
and Mumps
Source: Centers for Disease Control and Prevention, December 6,
2012 |
|
|
HTML | PDF |
| |
Use of Combination Measles,
Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory
Committee on Immunization Practices
Source: MMWR, May 7, 2010; 59(RR--3):1 - 16 |
|
| HTML | PDF |
| |
Control and Elimination
of Mumps
Source: MMWR, June 9, 2006, Vol. 55(22):629-630 |
|
| HTML | PDF |
| |
Measles, Mumps,
and Rubella--Vaccine Use and Strategies
Source: MMWR May 22, 1998 / Vol. 47 / No. RR-8 |
|
| HTML | PDF |
| # |
|
|
|
|
Prevention of
Plague
Source: MMWR December 13, 1996 / Vol. 45 / No. RR-14 |
|
| HTML | PDF |
| # |
|
|
|
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee
on Immunization Practices (ACIP)
Source: MMWR, February 22, 2013;62(07):131-5 |
|
|
HTML | PDF |
|
|
| |
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine
in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
Source: MMWR, June 29, 2012; 61(25):468-70 |
|
|
HTML | PDF |
|
| |
Updated Recommendations for Use of
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis
Vaccine (Tdap) in Pregnant Women and Persons Who Have or
Anticipate Having Close Contact with an Infant Aged <12 Months --
Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426 |
|
|
HTML | PDF |
| |
Updated Recommendations for Use of
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis
(Tdap) Vaccine from the Advisory Committee on Immunization
Practices, 2010
Source:: MMWR, January 14,
2011; 60(01):13-15 |
|
|
HTML | PDF |
| |
Prevention of Pertussis, Tetanus, and
Diphtheria Among Pregnant and Postpartum Women and Their Infants:
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 30, 2008; 57
(04):1-47,51 |
|
|
HTML pt 1 |
HTML pt 2 |
HTML pt 3 |
PDF |
| |
Preventing Tetanus,
Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced
Diphtheria Toxoid and Acellular Pertussis Vaccine
Please note: If you are using the HTML version of this
document, be sure to access all four HTML links to get the complete content
of the document,
which includes 3 important appendices.
Source: MMWR, December
15, 2006;55(RR-17):1-33 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | PDF
(entire issue) |
| |
Use of Tetanus Toxoid,
Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among
Adolescents
Please note: If you are using the HTML version of this document, be sure
to access all the HTML links to get the complete content of the document,
which includes important appendices.
Source:
MMWR, March 24, 2006, Vol. 55(RR03):1-49 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | HTML
pt.5 | HTML
pt.6 | HTML
pt.7 | PDF
(entire issue) |
| |
CDC
Treatment Guidelines: Recommended Antimicrobial Agents for the Treatment
and Postexposure Prophylaxis of Pertussis
(not an ACIP statement but a recommendation from NIP, CDC)
Source: MMWR, December 9, 2005, Vol. 54(RR14):1-16 |
|
| HTML | PDF |
| |
Use of Diphtheria
Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose
Series
Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13 |
|
| HTML | PDF |
| |
Use of Acellular
Pertussis Vaccines
Source: MMWR March 28, 1997 / Vol. 46 / No. RR-7 |
|
| HTML | PDF |
| |
Diphtheria,
Tetanus, and Pertussis, Recommendations for Vaccine Use and Other
Preventive Measures
Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10 |
|
| HTML | PDF |
| # |
|
|
|
|
Use of 13-Valent Pneumococcal
Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide
Vaccine for Adults with Immunocompromising Conditions:
Recommendations of the Advisory Committee on Immunization
Practices (ACIP)
Source: MMWR, October 12,
2012; 61(40):816-9 |
|
|
HTML | PDF |
| |
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
Source: MMWR, June 1, 2012; 61(21):394-5 |
|
|
HTML | PDF |
| |
Prevention of
Pneumococcal Disease Among Infants and Children--Use of 13-Valent
Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal
Polysaccharide Vaccine
Source: MMWR, December 10,
2010; 59(RR11):1-18 |
|
|
HTML | PDF |
| |
Updated ACIP
Recommendations: Prevention of Invasive Pneumococcal Disease Among
Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine
(PPSV23)
Source: MMWR, September 3, 2010; 59(34):1102-6 |
|
| HTML | PDF |
| |
Licensure of a 13-Valent
Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use
Among Children --- Advisory Committee on Immunization Practices
(ACIP), 2010
Source: MMWR, March 12, 2010;
59(09):258-261 |
|
| HTML | PDF |
| |
Updated Recommendation from the
Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent
Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24--59 Months Who
Are Not Completely Vaccinated
Source: MMWR, April 4, 2008; 57(13):343-344 |
|
| HTML | PDF |
| |
Pneumococcal Vaccination for Cochlear
Implant Candidates and Recipients
Source: MMWR, Early Release, July 31, 2003, Vol. 52;1-2 |
|
| HTML | PDF |
| |
Preventing
Pneumococcal Disease Among Infants and Young Children
Source: MMWR
October 6, 2000 / Vol. 49 / No. RR-09 |
|
| HTML | PDF |
| |
Prevention of
Pneumococcal Disease
Source: MMWR April 04, 1997 / Vol. 46 / No. RR-08 |
|
| HTML | PDF |
| # |
|
|
|
|
Poliomyelitis
Prevention in the United States
Source: MMWR May 19, 2000 / Vol. 49 / No. RR-05 |
|
| HTML | PDF |
| # |
|
|
|
|
Use of a Reduced (4-Dose)
Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies
Source: MMWR, March 19, 2010;
59(02):1-9 |
|
| HTML | PDF |
| |
Human Rabies Prevention--United
States, 2008: Recommendations of the Advisory Committee on Immunization
Practices
Source: MMWR, May 23, 2008; 57(RR03):1-26,28 |
|
|
HTML pt 1 |
HTML pt 2 | PDF |
| # |
|
|
Recommendations - Rotavirus |
|
|
|
Prevention of Rotavirus Gastroenteritis
Among Infants and Children: Recommendations of the Advisory Committee on
Immunization Practices
Source: MMWR, February 6, 2009, Vol. 58
(RR-2) |
|
| HTML | PDF |
| # |
|
|
Recommendations - Rubella |
|
|
|
ACIP Provisional Recommendations
Prevention of Measles, Rubella, Congenital Rubella Syndrome (CRS),
and Mumps
Source: Centers for Disease Control and Prevention, December 6,
2012 |
|
|
HTML | PDF |
| |
Use of Combination Measles,
Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory
Committee on Immunization Practices
Source: MMWR, May 7, 2010; 59(RR--3):1 - 16 |
|
| HTML | PDF |
| |
CDC Guidelines:
Evaluation and Management of Suspected Outbreaks, Rubella in Pregnant
Women, and Surveillance for Congenital Rubella Syndrome
(not an ACIP statement but an important update document)
Source: MMWR July 13, 2001 / Vol. 50 / No. RR-12 |
|
| HTML | PDF |
| |
Measles, Mumps,
and Rubella--Vaccine Use and Strategies
Source: MMWR May 22, 1998 / Vol. 47 / No. RR-8 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Shingles (zoster) |
|
|
|
Prevention of Herpes Zoster:
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 6, 2008; 57(05):1-30 |
|
| HTML | PDF |
| # |
|
|
|
|
Recommendations for Using Smallpox
Vaccine in a Pre-Event Vaccination Program
Source: MMWR, Recommendations and Reports, April 4, 2003, Vol. 52(RR-7) |
|
| HTML | PDF |
| |
Vaccinia (Smallpox)
Vaccine
Source: MMWR June 22, 2001 / Vol. 50 / No. RR-10 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Tetanus |
|
|
|
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee
on Immunization Practices (ACIP)
Source: MMWR, February 22, 2013;62(07):131-5 |
|
|
HTML | PDF |
|
|
| |
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine
in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
Source: MMWR, June 29, 2012; 61(25):468-70 |
|
|
HTML | PDF |
|
| |
Updated Recommendations for Use of
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis
Vaccine (Tdap) in Pregnant Women and Persons Who Have or
Anticipate Having Close Contact with an Infant Aged <12 Months --
Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426 |
|
|
HTML | PDF |
| |
Updated Recommendations for Use of
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis
(Tdap) Vaccine from the Advisory Committee on Immunization
Practices, 2010
Source: MMWR, January 14, 2011;
60(01):13-15 |
|
|
HTML | PDF |
| |
Prevention of Pertussis, Tetanus, and
Diphtheria Among Pregnant and Postpartum Women and Their Infants:
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 30, 2008; 57
(04):1-47,51 |
|
|
HTML pt 1 |
HTML pt 2 |
HTML pt 3 |
PDF |
| |
Preventing Tetanus,
Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced
Diphtheria Toxoid and Acellular Pertussis Vaccine
Please note: If you are using the HTML version of this
document, be sure to access all four HTML links to get the complete content
of the document,
which includes 3 important appendices.
Source: MMWR, December 15,
2006;55(RR-17):1-33 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | PDF
(entire issue) |
| |
Use of Tetanus Toxoid,
Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among
Adolescents
Please note: If you are using the HTML version
of this document, be sure to access all the HTML links to get the
complete content of the document,
which includes important appendices.
Source:
MMWR, March 24, 2006, Vol. 55(RR03):1-49 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | HTML
pt.5 | HTML
pt.6 | HTML
pt.7 | PDF
(entire issue) |
| |
Use of Diphtheria
Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose
Series
Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13 |
|
| HTML | PDF |
| |
Diphtheria,
Tetanus, and Pertussis, Recommendations for Vaccine Use and Other
Preventive Measures
Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10 |
|
| HTML | PDF |
| # |
|
|
Recommendations - Typhoid |
|
|
|
Typhoid Immunization
Source: MMWR December 9, 1994/ Vol. 43/ No. RR-14 |
|
| HTML | PDF |
| # |
|
|
|
|
Yellow Fever Vaccine:
Recommendations of the Advisory Committee on Immunization Practices
(ACIP)
Source: MMWR, July 30, 2010;
59(RR07):1-27 |
|
| HTML | PDF |
| |
Yellow Fever Vaccine
Source: MMWR, November 8, 2002, Vol. 51/RR17 |
|
| HTML | PDF |
|
| This
page was reviewed on
March 22, 2013 |
A-Z
IAC Home